Found 12 results
Author Title Type [ Year(Desc)]
Filters: Author is Karita, E  [Clear All Filters]
2007
W. Jaoko, Kayitenkore, K., G Manyonyi, O., Karita, E., Schmidt, C., Fast, P., Komaroff, W., Cooper, A., Boaz, M., Gilmour, J., Dally, L., Ho, M., Smith, C., and Graham, B., “Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
2008
W. Stevens, Kamali, A., Karita, E., Anzala, O., Sanders, E. J., Jaoko, W., Kaleebu, P., Mulenga, J., Dally, L., Fast, P., Gilmour, J., Farah, B., Birungi, J., Hughes, P., Manigart, O., Stevens, G., Yates, S., Thomson, H., ,, Stoll-Johnson, L., and Ketter, N., “Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials”, PLoS ONE, vol. 3, p. e2043, 2008.
A. Kamali, Karita, E., Kayitenkore, K., Kaleebu, P., Nanvubya, A., Anzala, O., Jaoko, W., Mutua, G., Ruzagira, E., Mulenga, J., Sanders, E., Mwangome, M., Allen, S., Amornkul, P., Price, M., Stevens, G., Dally, L., Excler, J., and , “A Cross-Sectional Study in Eastern and Southern Africa to Characterize Laboratory Reference Intervals in Healthy Adults for HIV Prevention Trials”, in AIDS Vaccine 2008 Conference, Cape Town, South Africa, 2008.
2009
E. Karita, Ketter, N., Price, M., Kayitenkore, K., Kaleebu, P., Nanvubya, A., Anzala, O., Jaoko, W., Mutua, G., Ruzagira, E., Mulenga, J., Sanders, E., Mwangome, M., Allen, S., Bwanika, A., Bahemuka, U., Awuondo, K., Omosa, G., Farah, B., Amornkul, P., Birungi, J., Yates, S., Stoll-Johnson, L., Gilmour, J., Stevens, G., Shutes, E., Manigart, O., Hughes, P., Dally, L., Scott, J., Stevens, W., Fast, P., and Kamali, S., “CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa”, PLoS ONE, vol. 4, no. 2, p. e4401, 2009.
2010
W. Jaoko, Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S., Than, S., Adams, E., Graham, B., Koup, R., Bailer, R., Smith, C., Dally, L., Farah, B., Anzala, O., Muvunyi, C., Bizimana, J., Tarragona-Fiol, T., Bergin, P., Hayes, P., Ho, M., Loughran, K., and Komaroff, W., “Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa”, PLoS ONE, vol. 5, p. e12873, 2010.
A. Spentzou, Bergin, P., Gill, D., Cheeseman, H., Ashraf, A., Kaltsidis, H., Cashin-Cox, M., Anjarwalla, I., Steele, A., Higgs, C., Pozniak, A., Piechocka-Trocha, A., Wong, J., Anzala, O., Karita, E., Dally, L., Gotch, F., Walker, B., Gilmour, J., and Hayes, P., “Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of Human Immunodeficiency Virus-1 Vaccine Candidates”, J Infect Dis, vol. 201, pp. 720-729, 2010.
2012
C. Schmidt, Smith, C., Barin, B., Bakhtyari, A., Bart, P. A., Bekker, L. G., Chomba, E., Clumeck, N., Ho, D., Hoosen, A., Jaoko, W., Kaleebu, P., Karita, E., Keefer, M. C., Lunzen, J. V., McMichael, A., Mehendale, S., Peters, B., Ramanathan, V. D., Robinson, A., Rockstroh, J., Vardas, E., Vets, E., Weber, J., Graham, B. S., Than, S., Excler, J. L., Kochhar, S., Ho, M., Heald, A., and Fast, P. E., “Background Morbidity in HIV Vaccine Trial Participants From Various Geographic Regions as Assessed by Unsolicited Adverse Events”, Hum Vaccin Immunother, vol. 8, no. 5, pp. 630-638, 2012.
2014
P. Hayes, Fernandez, N., Omosa-Manyonyi, G., Mpendo, J., Karita, E., Ruzagira, E., Kilembe, W., Mutua, G., Anzala, O., Roman, F., Bourguignon, P., Barin, B., Eldridge, J., Egan, M., Hannaman, D., Schmidt, C., Fast, P., Priddy, F., Cox, J., and Gilmour, J., “Assessment of Viral Inhibition Activity in Low Seroprevalent Adenovirus-35 Vectored HIV Vaccines +/- Adjuvanted Protein or Electroporated DNA”, in HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P), Cape Town, SA, 2014.
E. Karita, Anzala, O., Gazzard, B., Bergin, P., Nyombayire, J., Omosa, G., ,, Dally, L., Barin, B., Inoue, M., Hara, H., Hironaka, T., Shu, T., Hasegawa, M., Matano, T., Sayeed, E., Parks, C., Ackland, J., Fast, P., Gilmour, J., Cox, J., Lombardo, A., and Laufer, D., “Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers”, in HIVR4P (HIV Research for Prevention), Cape Town, South Africa, 2014.
G. Mutua, Mutengu, L., Mpendo, J., Kilembe, W., Omosa, G., Ruzagirwa, E., Karita, E., Page-Shipp, L., Gray, G., Bekker, L. G., Barin, B., Schmidt, C., Laufer, D., and Priddy, F., “Major Negative Social Impacts are Rare in Phase 1 HIV Vaccine Trials in Africa”, in HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P), Cape Town, SA, 2014.
2016
J. Nyombayire, Anzala, O., Gazzard, B., Karita, E., Bergin, P., Hayes, P., Kopycinski, J. T., Omosa, G., Jackson, A., Bizimana, J., Farah, B., Sayeed, E., Parks, C., Inoue, M., Gilmour, J., Lombardo, A., Fast, P. E., Laufer, D., and Cox, J. H., “Recombinant Sendai Vaccine Delivered Mucosally Induces Potent Gag-Specific T-Cell or Antibody Responses Depending on Prime Boost Regimen in Humans”, in HIV R4P 2016, Chicago, IL, 2016.
P. Kitandwe, Farah, B., Bizimana, J., Karita, E., Mutua, G., Mpendo, J., Omosa-Manyonyi, G., Bekker, L. G., L Baden, G., Lehrman, J., Laufer, G., Roman, F., Barin, B., Schmidt, C., Fast, P., Cox, J., Priddy, F., and Gelderblom, H., “Vaccine Induced HIV Seropositivity/Reactivity (VISP/R) Among Recipients of Adenovirus Vectored HIV-1 Vaccine Prime/Boost Regimens”, in HIV R4P 2016, Chicago, IL, 2016.